Table 5 Cox regression model: variables as predictors of mortality among patients with systolic heart failure (n = 78).
| Variable | HR (95% CI) | p Value |
|---|---|---|
| Age | 1.17 (1.023 to 1.338) | 0.02 |
| Female gender | 0.674 (0.104 to 4.366) | 0.67 |
| NYHA | 0.233 (0.035 to 1.573) | 0.13 |
| LVEF | 0.844 (0.754 to 0.944) | 0.003 |
| Hyperlipidemia | 1.176 (0.184 to 7.521) | 0.86 |
| Smoking | 3.033 (0.356 to 25.83) | 0.31 |
| Hypertension | 1.623 (0.221 to 11.939) | 0.63 |
| DM | 12.647 (1.778 to 89.966) | 0.01 |
| IHD | 0.457 (0.063 to 3.297) | 0.43 |
| EPC | 1.019 (1.002 to 1.036) | 0.02 |
| NT‐pro‐BNP | 1.16 (1.042 to 1.291) | 0.006 |
| hsCRP | 0.995 (0.968 to 1.023) | 0.71 |
| VEGF | 1.015 (0.998 to 1.033 | 0.07 |
DM, diabetes mellitus; EPC, endothelial progenitor cell; hsCRP, high‐sensitivity C‐reactive protein; IHD, ischaemic heart disease; LVEF, left ventricular ejection fraction; NT‐pro‐BNP, N‐terminal pro‐B‐type natriuretic peptide; NYHA, New York Heart Association; VEGF, vascular endothelial growth factor.